Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Foreign Clinical Trials: FDA Oversight To Include More Training, Data Collection

Executive Summary

Changes to FDA's policy for monitoring foreign clinical trials appear imminent after the Department of Health and Human Services Inspector General recommended the agency increase its oversight of data gathered outside the U.S

You may also be interested in...



Practice Makes Good: FDA, EMA Focus On CROs As GCP Info Sharing Improves

FDA and EMA need more time working together before they can rely on each other’s Good Clinical Practice inspection findings, a recent joint report concludes.

Practice Makes Good: FDA, EMA Focus On CROs As GCP Info Sharing Improves

FDA and EMA need more time working together before they can rely on each other’s Good Clinical Practice inspection findings, a recent joint report concludes.

Clinical Trials Face More FDA Scrutiny; DoJ Settlements Focus On Data Use

FDA is ratcheting up enforcement of clinical trial sites, conducting more inspections during the course of pivotal studies and issuing more warning letters to investigators.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS052369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel